Showing results (31-40 of 497) with videos related to

Sort By:
Pageof 50
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 6, 2025
Impact of National Comprehensive Cancer Network Guidelines Inclusion of Level 1 Evidence on Insurance Denial for Randomized Controlled Trial Patients with Metastatic Spine DiseaseUlysses G Gardner, Melissa M Brately, Raed J Zuhour, et al.
Journal of Biopharmaceutical Statistics|September 22, 2017
Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted BootstrapJincheng Shen, Lu Wang, Stephanie Daignault, et al.
The Journal of Urology|October 25, 2021
Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate CancerTimothy J Daskivich, Michael Luu, Stephen J Freedland, et al.
American Journal of Clinical Oncology|March 8, 2013
Image-guided radiation therapy for liver tumors: gastrointestinal histology mattersEvangelia Katsoulakis, Nadeem Riaz, Donald M Cannon, et al.
Current Opinion in Obstetrics & Gynecology|October 4, 2023
Latest advances in immuno-oncology for endometrial cancer: single-agent and combination regimensMichael Richardson, Dana M Chase
Prostate Cancer and Prostatic Diseases|September 3, 2021
Racial disparities in prostate cancer among black men: epidemiology and outcomesIlkania M Chowdhury-Paulino, Caroline Ericsson, Randy Vince, et al.
Prostate Cancer and Prostatic Diseases|January 8, 2025
Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancerPraful Ravi, Wanling Xie, Silke Gillessen, et al.
Paediatric Anaesthesia|December 24, 2018
Adverse events in radiation oncology: A case series from wake up safe, the pediatric anesthesia quality improvement initiativeRobert E Christensen, Rebecca C Nause-Osthoff, Jeffrey C Waldman, et al.
European Urology|April 2, 2013
A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapyZachary S Zumsteg, Daniel E Spratt, Isaac Pei, et al.
Future Oncology (London, England)|April 29, 2026
Real-world treatment patterns in patients with biochemical recurrence after local prostate cancer therapyRana R McKay, Nasreen Khan, Neal D Shore, et al.
Pageof 50